You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

康寧傑瑞製藥(09966.HK)KN026臨床試驗完成首例患者給藥

阿思達克 07-30 21:49
康寧傑瑞製藥－Ｂ(09966.HK)公布，KN026在內地的隨機、對照、開放及多中心III期臨床試驗已成功完成首例患者給藥，旨在比較KN026聯合HB1801與曲妥珠單抗聯合帕妥珠單抗及多西他賽一線治療HER2陽性複發性或轉移性乳腺癌的療效及安全性。
康寧傑瑞製藥-B(09966.HK)
Relevant Stocks
康寧傑瑞製藥-B(09966.HK)
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.